tradingkey.logo

Tyra Biosciences Inc <TYRA.OQ> expected to post a loss of 49 cents a share - Earnings Preview

ReutersMay 5, 2025 10:51 PM
  • Tyra Biosciences Inc TYRA.OQ TYRA.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Tyra Biosciences Inc is for a loss of 49 cents per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Tyra Biosciences Inc is $30.00​, above​ its last closing price of $10.50. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.42

-0.48

-0.43

Beat

10.5

Sep. 30 2024

-0.39

-0.40

-0.41

Missed

-2.8

Jun. 30 2024

-0.39

-0.41

-0.32

Beat

21.6​

Mar. 31 2024

-0.46

-0.46

-0.35

Beat

23.1

​​Dec. 31 2023

-0.43

-0.48

-0.53

Missed

-10.3

Sep. 30 2023

-0.37

-0.35

-0.49

Missed

-38.9​

Jun. 30 2023

-0.32

-0.34

-0.31

Beat

9.8

Mar. 31 2023

-0.37

-0.37

-0.28

Beat

23.5

This summary was machine generated May 5 at 22:51 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI